Search - tctmd.com

Displaying 521 - 540 of 560

Sort: Relevancy | Date

News Daily News

In-Hospital Bleeding, Mortality Linked Long After NSTEMI

Caitlin E. Cox

March 12, 2012

News Daily News

Stem Cell Therapy Moderately Improves Cardiac Function After Acute MI

L.A. McKeown

March 07, 2012

News Daily News

HORIZONS-AMI: Radial Access PCI Reduces Bleeding, MACE in STEMI

March 07, 2012

News Daily News

HORIZONS-AMI: Las PCI mediante Acceso Radial Reducen las Hemorragias y los MACE en los STEMI

March 07, 2012

News Conference News Cell Therapy 2012

Expedited Cell Therapy After STEMI Shows Promise

January 29, 2012

News Daily News

Meta-Analysis Shows Increased Risk of MI, ACS with Dabigatran

L.A. McKeown

January 09, 2012

News Daily News

LIPSIA: No Rush for Treatment of High-Risk NSTEMI Patients

Leah Lawrence

December 08, 2011

News Daily News

FFR-Guidance Demonstrates Benefits in Patients with Unstable Angina, NSTEMI

L.A. McKeown

December 08, 2011

News Daily News

STEMI Patients Not Achieving Recommended Transfer Times for PCI

L.A. McKeown

December 05, 2011

News Daily News

Hospital Readmission Post-PCI Linked to Increased Mortality

Yael L. Maxwell

December 05, 2011

News Conference News

Adenosine-Free Pressure Measurement Found Equivalent to FFR

L.A. McKeown

December 01, 2011

News Conference News

Prasugrel Bests Double Clopidogrel Dose for STEMI Patients with High Residual Platelet Reactivity

November 17, 2011

News Conference News

MI FREEE: Free Post-MI Drugs Reduce Events, Costs

November 15, 2011

News Conference News

ISAR-REACT 4: Bivalirudin Reduces Major Bleeding in NSTEMI Patients

November 13, 2011

News Conference News

AIDA STEMI: No Advantage for Intracoronary vs. Intravenous Abciximab

November 13, 2011

News Daily News

Meta-analysis: Intracoronary vs. IV Abciximab Improves Survival in STEMI Patients

L.A. McKeown

November 01, 2011

News Daily News

Hope Renewed for Novel Anticoagulant Use in ACS

Caitlin E. Cox

October 05, 2011

News Daily News

Novel Peptide During Primary PCI Helps Limit Reperfusion Injury

Caitlin E. Cox

September 23, 2011

News Daily News

Prothrombin Works as Antidote to Rivaroxaban, Not Dabigatran

L.A. McKeown

September 13, 2011

News Conference News

ESC Congress 2011: Drugs, Devices Work Together

Caitlin E. Cox

September 06, 2011

Advertisement

In-Hospital Bleeding, Mortality Linked Long After NSTEMI

Stem Cell Therapy Moderately Improves Cardiac Function After Acute MI

HORIZONS-AMI: Radial Access PCI Reduces Bleeding, MACE in STEMI

HORIZONS-AMI: Las PCI mediante Acceso Radial Reducen las Hemorragias y los MACE en los STEMI

Expedited Cell Therapy After STEMI Shows Promise

Meta-Analysis Shows Increased Risk of MI, ACS with Dabigatran

LIPSIA: No Rush for Treatment of High-Risk NSTEMI Patients

FFR-Guidance Demonstrates Benefits in Patients with Unstable Angina, NSTEMI

STEMI Patients Not Achieving Recommended Transfer Times for PCI

Hospital Readmission Post-PCI Linked to Increased Mortality

Adenosine-Free Pressure Measurement Found Equivalent to FFR

Prasugrel Bests Double Clopidogrel Dose for STEMI Patients with High Residual Platelet Reactivity

MI FREEE: Free Post-MI Drugs Reduce Events, Costs

ISAR-REACT 4: Bivalirudin Reduces Major Bleeding in NSTEMI Patients

AIDA STEMI: No Advantage for Intracoronary vs. Intravenous Abciximab

Meta-analysis: Intracoronary vs. IV Abciximab Improves Survival in STEMI Patients

Hope Renewed for Novel Anticoagulant Use in ACS

Novel Peptide During Primary PCI Helps Limit Reperfusion Injury

Prothrombin Works as Antidote to Rivaroxaban, Not Dabigatran

ESC Congress 2011: Drugs, Devices Work Together

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content